Published in J Clin Microbiol on August 01, 2006
Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol (2008) 1.89
Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect (2008) 1.14
HIV-1, HSV-2 and syphilis among pregnant women in a rural area of Tanzania: prevalence and risk factors. BMC Infect Dis (2008) 1.02
Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease. Med Microbiol Immunol (2014) 0.80
Seroepidemiology of herpes simplex virus type 1 and 2 in northern iran. Iran J Public Health (2012) 0.79
Human herpes simplex virus type 1 in confiscated gorilla. Emerg Infect Dis (2014) 0.79
Herpes simplex virus type 2 cross-sectional seroprevalence and the estimated rate of neonatal infections among a cohort of rural Malawian female adolescents. Sex Transm Infect (2013) 0.78
Seroprevalence of CMV, HSV-2 and HBV among HIV-Infected Malawian Children: A Cross-sectional Survey. J Trop Pediatr (2016) 0.75
Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007. PLoS One (2015) 0.75
Diet-induced obesity prolongs neuroinflammation and recruits CCR2(+) monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice. Brain Behav Immun (2016) 0.75
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09
Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59
Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol (1973) 6.60
Genetic relatedness of type 1 and type 2 herpes simplex viruses. J Virol (1972) 5.11
Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis (2002) 5.09
Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet (1998) 4.48
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl (1990) 4.02
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19
Temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1971) 3.04
Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64
Genital herpes and public health: addressing a global problem. JAMA (2000) 2.60
Sorting out the new HSV type specific antibody tests. Sex Transm Infect (2001) 2.54
Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol (2002) 2.39
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J Virol (1986) 2.07
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis (2000) 1.90
Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods (1992) 1.86
Genital herpes infection: a review. Int J Epidemiol (1997) 1.84
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis (1988) 1.44
Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis (1997) 1.40
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol (1998) 1.37
First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect (2000) 1.28
An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect (1998) 1.10
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol (1999) 1.08
Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. J Virol Methods (2002) 1.06
Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol (1994) 1.02
Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand (2000) 1.01
Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol (2002) 1.01
Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J Med Virol (1998) 0.95
Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int J STD AIDS (1998) 0.94
Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol Infect (2005) 0.88
Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera. J Virol Methods (2000) 0.88
The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis (2004) 0.87
Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis (2003) 0.87
Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera. J Virol Methods (2003) 0.83
Sexually transmitted herpes simplex viruses. Scand J Infect Dis (2004) 0.83
Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int J STD AIDS (2000) 0.82
A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles. J Virol Methods (2004) 0.80
A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-1 reacts sensitively and specifically with HSV-1 antibodies in an ELISA. J Virol Methods (2005) 0.79
Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol (2004) 3.92
High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol (2005) 2.24
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. Hepatology (2014) 2.17
Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis (2007) 2.05
Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. Hepatology (2008) 1.98
Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut (2011) 1.95
Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry (2013) 1.63
LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet (2003) 1.59
A large community outbreak of waterborne giardiasis-delayed detection in a non-endemic urban area. BMC Public Health (2006) 1.57
Identification of diarrheagenic Escherichia coli isolated from infants and children in Dar es Salaam, Tanzania. BMC Infect Dis (2007) 1.54
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol (2004) 1.51
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol (2006) 1.49
Glycoconjugate glycans as viral receptors. Ann Med (2005) 1.48
Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol (2009) 1.48
Direct 16S rRNA gene sequencing from clinical specimens, with special focus on polybacterial samples and interpretation of mixed DNA chromatograms. J Clin Microbiol (2009) 1.43
Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health (2004) 1.43
Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis (2005) 1.37
Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in Dar es Salaam, Tanzania. BMC Pediatr (2011) 1.34
Valganciclovir in patients with glioblastoma. N Engl J Med (2013) 1.21
Protein-protein interactions as targets for antiviral chemotherapy. Rev Med Virol (2002) 1.21
Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol (2009) 1.19
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology (2010) 1.17
Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol (2007) 1.16
Nosocomial outbreak of neonatal Salmonella enterica serotype Enteritidis meningitis in a rural hospital in northern Tanzania. BMC Infect Dis (2004) 1.16
Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors (2012) 1.14
Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol (2010) 1.13
A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. Malar J (2013) 1.12
Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect (2007) 1.11
Severe malaria and artesunate treatment, Norway. Emerg Infect Dis (2008) 1.11
Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J (2005) 1.09
Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. Scand J Infect Dis (2005) 1.08
Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay. BMC Infect Dis (2008) 1.08
Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus. J Infect Dis (2011) 1.08
Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol (2005) 1.08
Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area. Diagn Mol Pathol (2008) 1.07
Detection of bacterial DNA in painful degenerated spinal discs in patients without signs of clinical infection. Eur Spine J (2004) 1.07
Human Tick-Borne Encephalitis and Characterization of Virus from Biting Tick. Emerg Infect Dis (2016) 1.07
Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J Clin Microbiol (2003) 1.07
Prevalence of enteropathogenic viruses and molecular characterization of group A rotavirus among children with diarrhea in Dar es Salaam Tanzania. BMC Public Health (2007) 1.06
Enteric viruses in healthy children in Cameroon: viral load and genotyping of norovirus strains. J Med Virol (2011) 1.05
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res (2004) 1.05
Characterization of polybacterial clinical samples using a set of group-specific broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis. J Med Microbiol (2011) 1.05
Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J Biol Chem (2006) 1.05
Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J Biol Chem (2005) 1.04
Dual priming oligonucleotides for broad-range amplification of the bacterial 16S rRNA gene directly from human clinical specimens. J Clin Microbiol (2012) 1.03
A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations. PLoS One (2011) 1.03
HIV-1, HSV-2 and syphilis among pregnant women in a rural area of Tanzania: prevalence and risk factors. BMC Infect Dis (2008) 1.02
Falciparum malaria and HIV-1 in hospitalized adults in Maputo, Mozambique: does HIV-infection obscure the malaria diagnosis? Malar J (2008) 1.02
Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit. J Virol (2003) 1.01
Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol (2002) 1.01
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One (2011) 1.01
Herpes simplex virus infection and genital ulcer disease among patients with sexually transmitted infections in Dar es Salaam, Tanzania. Acta Derm Venereol (2007) 1.00
Challenges in diagnosing paediatric malaria in Dar es Salaam, Tanzania. Malar J (2013) 1.00
Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology (2004) 0.99
Genetic recombination of tick-borne flaviviruses among wild-type strains. Virology (2013) 0.97
[Aminoglycosides can reduce the risk]. Tidsskr Nor Laegeforen (2013) 0.96
A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility. Scand J Infect Dis (2005) 0.96
Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates. J Clin Microbiol (2002) 0.95
Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. J Antimicrob Chemother (2011) 0.94
Lifestyle and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurol Scand (2004) 0.94
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. PLoS One (2012) 0.94
Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes. J Clin Microbiol (2006) 0.94
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One (2008) 0.94
Recombination of Globally Circulating Varicella-Zoster Virus. J Virol (2015) 0.94
Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol (2002) 0.93
Molecular analysis of an oyster-related norovirus outbreak. J Clin Virol (2009) 0.92
Comparison of rectal swabs and faeces for real-time PCR detection of enteric agents in Rwandan children with gastroenteritis. BMC Infect Dis (2013) 0.92
Human cellular immune response against Giardia lamblia 5 years after acute giardiasis. J Infect Dis (2011) 0.91
Prevalence and molecular characterisation of human adenovirus in diarrhoeic children in Tanzania; a case control study. BMC Infect Dis (2014) 0.91
Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital. BMC Infect Dis (2014) 0.91
Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. Virology (2002) 0.91
Penicillin resistance and serotype distribution of Streptococcus pneumoniae in nasopharyngeal carrier children under 5 years of age in Dar es Salaam, Tanzania. J Med Microbiol (2012) 0.91
Shift of Enterovirus species among children in Cameroon--identification of a new enterovirus, EV-A119. J Clin Virol (2013) 0.90
Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs (2013) 0.90
Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infect Dis (2009) 0.90
Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol Pharm Bull (2008) 0.90
Tracing of norovirus outbreak strains in mussels collected near sewage effluents. Appl Environ Microbiol (2008) 0.89
Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. APMIS (2008) 0.89
Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania. J Clin Virol (2002) 0.89
Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scand J Gastroenterol (2013) 0.88
Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. BMC Infect Dis (2012) 0.88
Marked genomic diversity of norovirus genogroup I strains in a waterborne outbreak. Appl Environ Microbiol (2012) 0.88
Frequent detection of cytomegalovirus and Epstein-Barr virus in cervical secretions from healthy young women. Acta Obstet Gynecol Scand (2013) 0.87
Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis (2003) 0.87
Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J Gen Virol (2002) 0.87
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz (2008) 0.86
The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res (2008) 0.86
Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity. Glycobiology (2004) 0.86
Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy. AIDS Res Hum Retroviruses (2002) 0.86
Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology. J Virol Methods (2011) 0.86
Fever in the tropics: aetiology and case-fatality - a prospective observational study in a tertiary care hospital in South India. BMC Infect Dis (2013) 0.86
Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. BMC Gastroenterol (2013) 0.86
Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol (2005) 0.85
Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease. J Virol (2012) 0.85
Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome. J Inflamm (Lond) (2010) 0.85
The core 2 beta-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins. J Gen Virol (2004) 0.85
Real-time PCR identification of agents causing diarrhea in Rwandan children less than 5 years of age. Pediatr Infect Dis J (2014) 0.85